prednisolone has been researched along with Cardiomyopathies in 67 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
Excerpt | Relevance | Reference |
---|---|---|
"Our objective was to evaluate the effectiveness of combination therapy consisting of low-dose corticosteroids with weekly methotrexate in patients with cardiac sarcoidosis in whom long-term therapy is required." | 9.19 | Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. ( Handa, T; Ikezoe, K; Ito, Y; Izumi, T; Nagai, S; Ogino, S; Tanizawa, K; Yokomatsu, T, 2014) |
"Prednisolone (PSL) therapy is the gold standard treatment in patients with cardiac sarcoidosis (CS)." | 7.83 | Effect of Discontinuation of Prednisolone Therapy on Risk of Cardiac Mortality Associated With Worsening Left Ventricular Dysfunction in Cardiac Sarcoidosis. ( Aiba, T; Anzai, T; Asaumi, Y; Kanzaki, H; Kusano, K; Nagai, T; Nagano, N; Noguchi, T; Ogawa, H; Sugano, Y; Yasuda, S, 2016) |
"Our objective was to evaluate the effectiveness of combination therapy consisting of low-dose corticosteroids with weekly methotrexate in patients with cardiac sarcoidosis in whom long-term therapy is required." | 5.19 | Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. ( Handa, T; Ikezoe, K; Ito, Y; Izumi, T; Nagai, S; Ogino, S; Tanizawa, K; Yokomatsu, T, 2014) |
"Prednisolone (PSL) therapy is the gold standard treatment in patients with cardiac sarcoidosis (CS)." | 3.83 | Effect of Discontinuation of Prednisolone Therapy on Risk of Cardiac Mortality Associated With Worsening Left Ventricular Dysfunction in Cardiac Sarcoidosis. ( Aiba, T; Anzai, T; Asaumi, Y; Kanzaki, H; Kusano, K; Nagai, T; Nagano, N; Noguchi, T; Ogawa, H; Sugano, Y; Yasuda, S, 2016) |
"BDS is a predictive marker of recurrence and MACE." | 1.62 | Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET. ( Ando, K; Fukushima, K; Hagiwara, N; Imamura, Y; Momose, M; Nagao, M; Nakao, R; Sakai, A; Sakai, S; Suzuki, A; Watanabe, E; Yamamoto, A, 2021) |
"Cardiac sarcoidosis is an infiltrative, granulomatous inflammatory disease of the myocardium." | 1.42 | What type of different clinical manifestations can cardiac sarcoidosis present? ( Argüder, E; Baştuğ, S; Hasanoğlu, HC; Karabekir, E; Karalezli, A; Maraş, Y; Öğüt, T; Şentürk, A, 2015) |
"She had been treated for cardiac sarcoidosis with prednisolone, and she had undergone pacemaker implantation because of advanced complete A-V block 5 years before." | 1.42 | [Successful mitral valve replacement in a patient with functional mitral regurgitation induced by cardiac sarcoidosis;report of a case]. ( Aizawa, K; Misawa, Y; Sato, K; Takazawa, I, 2015) |
" All patients were treated with 30mg/day of prednisone after device implantation, which was tapered to a maintenance dosage of 5-10mg/day." | 1.39 | Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. ( Hayashi, H; Hayashi, M; Horie, T; Iwasaki, YK; Miyauchi, Y; Seino, Y; Shimizu, W; Shiomura, R; Takahashi, K; Tsuboi, I; Uetake, S; Yodogawa, K, 2013) |
"Captopril treatment resulted in indirect myocardial effects of reduced afterload and direct effects of increased contractility." | 1.35 | Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy. ( Bauer, R; Blain, A; Bushby, K; MacGowan, GA; Straub, V, 2009) |
"Prednisolone was administered daily." | 1.35 | A failed case to diagnose cardiac sarcoidosis presenting advanced atrioventricular block. ( Hibino, T; Hiramitsu, S; Ichiro Morimoto, S; Kako, N; Kato, K; Kato, Y; Kuroda, M; Mizoguchi, Y; Morikawa, M; Oguri, M; Yajima, K; Yokoi, K, 2008) |
"A total of 141 consecutive patients treated for sarcoidosis were studied." | 1.34 | Clinical analysis of sarcoidosis presenting with heterochronic cardiac involvement. ( Chida, K; Inui, N; Miwa, S; Morita, S; Sato, J; Suda, T, 2007) |
" Upon successive dose reduction to a maintenance dosage of 10 mg prednisolone, the patient's clinical status and peripheral blood count remained stable." | 1.33 | Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy. ( Fries, JW; Hoppe, UC; Huntgeburth, M; Lindner, M, 2005) |
"Cardiac sarcoidosis was diagnosed by a defect of Thallium-201 (Tl-201) imaging and abnormal uptake of Gallium-67 (Ga-67)." | 1.31 | Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of gallium-67 and thallium-201 scintigraphy. ( Ijiri, H; Ishihara, T; Kohno, I; Komori, S; Sawanobori, T; Tamura, K; Umetani, K; Yamamoto, K, 2000) |
"Prednisolone was administered and the abnormal accumulation of the scintigra ms disappeared." | 1.31 | Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis. Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis. ( Aizawa, Y; Chinushi, M; Chinushi, Y; Ebe, K; Furushima, H; Mezaki, T; Okumura, H; Washizuka, T, 2001) |
"Pulmonary sarcoidosis was diagnosed by transbronchial lung biopsy in a 27-year old man admitted to our hospital in September 1996." | 1.31 | [A case of sarcoidosis involving multiple organs that showed significant improvement as the serum KL-6 level fell after steroid therapy]. ( Hagimoto, N; Hara, N; Kawasaki, M; Kuwano, K; Matsuba, T; Tanaka, A; Yoshida, K, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (20.90) | 18.7374 |
1990's | 6 (8.96) | 18.2507 |
2000's | 18 (26.87) | 29.6817 |
2010's | 23 (34.33) | 24.3611 |
2020's | 6 (8.96) | 2.80 |
Authors | Studies |
---|---|
Ishizuka, M | 1 |
Kashimura, T | 1 |
Watanabe, M | 1 |
Kase, M | 1 |
Sakai, R | 1 |
Okubo, T | 1 |
Fujiki, S | 1 |
Takayama, T | 1 |
Ishihara, S | 1 |
Ozaki, K | 1 |
Inomata, T | 1 |
Dinesh Kumar, J | 1 |
Geminiganesan, S | 1 |
Padmanaban, R | 1 |
Pinnaka, S | 1 |
Chandrasekar, T | 1 |
Khandkar, C | 1 |
Vaidya, K | 1 |
Penglase, R | 1 |
Cai, K | 1 |
Shin, JS | 1 |
Hunyor, I | 1 |
Keech, A | 1 |
McGill, N | 1 |
Trucco, F | 1 |
Domingos, JP | 1 |
Tay, CG | 1 |
Ridout, D | 1 |
Maresh, K | 1 |
Munot, P | 1 |
Sarkozy, A | 1 |
Robb, S | 1 |
Quinlivan, R | 1 |
Riley, M | 1 |
Burch, M | 1 |
Fenton, M | 1 |
Wallis, C | 1 |
Chan, E | 1 |
Abel, F | 1 |
Manzur, AY | 1 |
Muntoni, F | 1 |
Takahashi, F | 1 |
Sawada, J | 1 |
Minoshima, A | 1 |
Sakamoto, N | 1 |
Ono, T | 1 |
Akasaka, K | 1 |
Takei, H | 1 |
Nishino, I | 1 |
Hasebe, N | 1 |
Yamamoto, A | 1 |
Nagao, M | 1 |
Watanabe, E | 1 |
Imamura, Y | 1 |
Suzuki, A | 1 |
Fukushima, K | 1 |
Ando, K | 1 |
Nakao, R | 1 |
Sakai, A | 1 |
Momose, M | 1 |
Sakai, S | 1 |
Hagiwara, N | 1 |
Wangkaew, S | 1 |
Lertthanaphok, S | 1 |
Puntana, S | 1 |
Noppakun, K | 1 |
Waki, H | 1 |
Eguchi, K | 1 |
Toriumi, S | 1 |
Ikemoto, T | 1 |
Suzuki, T | 1 |
Fukushima, N | 1 |
Kario, K | 1 |
Higuchi, Y | 1 |
Kimoto, Y | 1 |
Tanoue, R | 1 |
Tokunou, T | 1 |
Tomonari, K | 1 |
Maeda, T | 1 |
Horiuchi, T | 1 |
Heier, CR | 1 |
Yu, Q | 1 |
Fiorillo, AA | 1 |
Tully, CB | 1 |
Tucker, A | 1 |
Mazala, DA | 1 |
Uaesoontrachoon, K | 1 |
Srinivassane, S | 1 |
Damsker, JM | 1 |
Hoffman, EP | 1 |
Nagaraju, K | 1 |
Spurney, CF | 1 |
Karavelioglu, Y | 1 |
Baran, A | 1 |
Karapinar, H | 1 |
Küçükdurmaz, Z | 1 |
Yilmaz, A | 1 |
Berkenboom, G | 1 |
Hulet, F | 1 |
Remmelink, M | 1 |
Unger, P | 1 |
Yodogawa, K | 1 |
Seino, Y | 1 |
Shiomura, R | 1 |
Takahashi, K | 1 |
Tsuboi, I | 1 |
Uetake, S | 1 |
Hayashi, H | 1 |
Horie, T | 1 |
Iwasaki, YK | 1 |
Hayashi, M | 1 |
Miyauchi, Y | 1 |
Shimizu, W | 1 |
Miyagi, R | 1 |
Ideguchi, H | 1 |
Soga, T | 1 |
Yamakawa, Y | 1 |
Otsuki, H | 1 |
Niino, H | 1 |
Shiina, T | 1 |
Ueda, A | 1 |
Ishigatsubo, Y | 1 |
Nagai, S | 2 |
Yokomatsu, T | 2 |
Tanizawa, K | 2 |
Ikezoe, K | 2 |
Handa, T | 2 |
Ito, Y | 2 |
Ogino, S | 2 |
Izumi, T | 2 |
Nureki, S | 1 |
Miyazaki, E | 1 |
Nishio, S | 1 |
Ehara, C | 1 |
Yamasue, M | 1 |
Ando, M | 1 |
Kadota, J | 1 |
Şentürk, A | 1 |
Maraş, Y | 1 |
Argüder, E | 1 |
Karalezli, A | 1 |
Hasanoğlu, HC | 1 |
Öğüt, T | 1 |
Baştuğ, S | 1 |
Karabekir, E | 1 |
Martusewicz-Boros, MM | 1 |
Wiatr, E | 1 |
Roszkowski-Sliz, K | 1 |
Sato, K | 1 |
Takazawa, I | 1 |
Aizawa, K | 1 |
Misawa, Y | 1 |
Nagai, T | 2 |
Nagano, N | 1 |
Sugano, Y | 1 |
Asaumi, Y | 1 |
Aiba, T | 1 |
Kanzaki, H | 2 |
Kusano, K | 1 |
Noguchi, T | 1 |
Yasuda, S | 1 |
Ogawa, H | 1 |
Anzai, T | 1 |
Takahashi, Y | 1 |
Izumi, C | 1 |
Miyake, M | 1 |
Nakajima, S | 1 |
Nishimura, S | 1 |
Kuroda, M | 2 |
Yoshikawa, Y | 1 |
Amano, M | 1 |
Hayama, Y | 1 |
Imamura, S | 1 |
Onishi, N | 1 |
Tamaki, Y | 1 |
Enomoto, S | 1 |
Tamura, T | 2 |
Kondo, H | 1 |
Kaitani, K | 1 |
Nakagawa, Y | 1 |
Pal, S | 1 |
Karagiannis, G | 1 |
Dubrey, SW | 2 |
Kim, BH | 1 |
Kim, JH | 1 |
Shim, BJ | 1 |
Park, MY | 1 |
Bauer, R | 1 |
Straub, V | 1 |
Blain, A | 1 |
Bushby, K | 1 |
MacGowan, GA | 1 |
Miyazaki, S | 1 |
Funabashi, N | 1 |
Uehara, M | 1 |
Kataoka, A | 1 |
Takaoka, H | 1 |
Ueda, M | 1 |
Komuro, I | 1 |
Hsieh, YC | 1 |
Huang, JL | 1 |
Chin, CS | 1 |
Lin, TC | 1 |
Liao, YC | 1 |
Ting, CT | 1 |
Wu, TJ | 1 |
Sato, T | 2 |
Ishida, Y | 1 |
Amaki, M | 1 |
Ohara, T | 1 |
Hasegawa, T | 1 |
Hashimura, K | 1 |
Nakatani, S | 2 |
Yamada, N | 2 |
Ikeda, Y | 1 |
Ueda-Ishibashi, H | 1 |
Kitakaze, M | 2 |
Takasugi, N | 1 |
Kubota, T | 1 |
Kawamura, I | 1 |
Takasugi, M | 1 |
Kanamori, H | 1 |
Ushikoshi, H | 1 |
Hattori, A | 1 |
Aoyama, T | 1 |
Kawasaki, M | 2 |
Nishigaki, K | 1 |
Takemura, G | 1 |
Minatoguchi, S | 1 |
Sugizaki, Y | 1 |
Tanaka, H | 1 |
Imanishi, J | 1 |
Konishi, A | 1 |
Yamashita, T | 1 |
Shinke, T | 1 |
Ishida, T | 1 |
Kawai, H | 1 |
Hirata, K | 1 |
Uemura, A | 2 |
Morimoto, S | 2 |
Morita, H | 1 |
Yokoyama, I | 1 |
Uno, K | 1 |
Nagai, R | 1 |
Chiu, CZ | 1 |
Zhang, G | 1 |
Tachibana, T | 2 |
Ohmori, F | 2 |
Yamagishi, M | 1 |
Tomoike, H | 1 |
Miyatake, K | 1 |
Hagiwara, K | 1 |
Nishikido, A | 1 |
Miyamoto, S | 1 |
Komiyama, K | 1 |
Matsuno, H | 1 |
Hashida, H | 1 |
Kobayakawa, N | 1 |
Akiyama, O | 1 |
Huntgeburth, M | 1 |
Lindner, M | 1 |
Fries, JW | 1 |
Hoppe, UC | 1 |
Hiramitsu, S | 2 |
Kato, Y | 2 |
Kimura, K | 1 |
Ohtsuki, M | 1 |
Kato, S | 1 |
Sugiura, A | 1 |
Miyagishima, K | 1 |
Hishida, H | 1 |
Sugisaki, K | 1 |
Tsuda, T | 1 |
Kiuchi, S | 1 |
Teraoka, K | 1 |
Koizumi, K | 1 |
Takazawa, K | 1 |
Yamashina, A | 1 |
Miwa, S | 1 |
Suda, T | 1 |
Morita, S | 1 |
Inui, N | 1 |
Sato, J | 1 |
Chida, K | 1 |
Morikawa, M | 1 |
Kato, K | 1 |
Kako, N | 1 |
Oguri, M | 1 |
Yajima, K | 1 |
Hibino, T | 1 |
Mizoguchi, Y | 1 |
Yokoi, K | 1 |
Ichiro Morimoto, S | 1 |
Hiramastu, S | 1 |
Tada, H | 1 |
Naito, S | 1 |
Oshima, S | 1 |
Taniguchi, K | 1 |
Kanemitsu, S | 1 |
Miyake, Y | 1 |
Okabe, M | 1 |
Ishikawa, T | 1 |
Kondoh, H | 1 |
Nakagawa, S | 1 |
Koiwaya, Y | 1 |
Tanaka, K | 1 |
Georgiev, S | 1 |
Khadzhipetrov, N | 1 |
Anders, O | 1 |
Konrad, H | 1 |
Pflücke, F | 1 |
Nizze, H | 1 |
Huth, J | 1 |
Dorent, R | 1 |
Pavie, A | 1 |
Nataf, P | 1 |
Tedy, G | 1 |
Vaissier, E | 1 |
Ghoussoub, JJ | 1 |
Bors, V | 1 |
Gandjbakhch, I | 1 |
Sugo, A | 1 |
Seyama, K | 1 |
Yaguchi, T | 1 |
Noto, K | 1 |
Kira, S | 1 |
Yamaguchi, H | 1 |
Park, HC | 1 |
Kim, SK | 2 |
Kim, YS | 1 |
Chang, J | 1 |
Chung, KY | 1 |
Shin, DH | 1 |
Lee, WY | 1 |
Kim, SS | 1 |
Cha, K | 1 |
Anderson, J | 1 |
Chamarthi, B | 1 |
Reisinger, J | 1 |
Skinner, M | 1 |
Falk, RH | 1 |
Doherty, MJ | 1 |
Kumar, SK | 1 |
Nicholson, AA | 1 |
McGivern, DV | 1 |
Umetani, K | 1 |
Ishihara, T | 1 |
Yamamoto, K | 1 |
Sawanobori, T | 1 |
Kohno, I | 1 |
Ijiri, H | 1 |
Komori, S | 1 |
Tamura, K | 1 |
Hufnagel, G | 1 |
Pankuweit, S | 1 |
Richter, A | 1 |
Schönian, U | 1 |
Maisch, B | 1 |
Chinushi, M | 2 |
Mezaki, T | 2 |
Aoki, Y | 1 |
Nakagawa, I | 1 |
Washizuka, T | 2 |
Aizawa, Y | 2 |
Shimada, T | 1 |
Shimada, K | 1 |
Sakane, T | 1 |
Ochiai, K | 1 |
Tsukihashi, H | 1 |
Fukui, M | 1 |
Inoue, S | 1 |
Katoh, H | 1 |
Murakami, Y | 1 |
Ishibashi, Y | 1 |
Maruyama, R | 1 |
Furushima, H | 1 |
Chinushi, Y | 1 |
Ebe, K | 1 |
Okumura, H | 1 |
Tanaka, A | 1 |
Kuwano, K | 1 |
Matsuba, T | 1 |
Yoshida, K | 1 |
Hagimoto, N | 1 |
Hara, N | 1 |
Prugberger, E | 1 |
Friedman, HS | 1 |
Parikh, NK | 1 |
Chander, N | 1 |
Calderon, J | 1 |
Schaedel, H | 2 |
Kirsten, D | 2 |
Schmidt, A | 1 |
Schmidt, H | 1 |
Strauss, HJ | 1 |
Hokamura, Y | 1 |
Shono, H | 1 |
Uchida, H | 1 |
Kimura, Y | 1 |
Takenaka, S | 1 |
Fukuda, K | 1 |
Shima, K | 1 |
Hamada, T | 1 |
Yoshimura, M | 1 |
Ueda, E | 1 |
Taniguchi, H | 1 |
Iwasaka, K | 1 |
Nakamori, H | 1 |
Onoyama, H | 1 |
Matsuura, T | 1 |
Takayama, Y | 1 |
Sumimoto, T | 1 |
Sugiura, T | 1 |
Ichibangase, J | 1 |
Inada, M | 1 |
Kodama, M | 1 |
Baba, M | 1 |
Takeuchi, A | 1 |
Hashimoto, T | 1 |
Miyashita, H | 1 |
Takatsu, M | 1 |
Toyoda, M | 1 |
Saksonov, SI | 1 |
Morenova, GN | 1 |
Saksonova, MT | 1 |
Barthelmes, H | 1 |
Barnard, CN | 1 |
Selye, H | 1 |
Pennoit, H | 1 |
Bekaert, S | 1 |
Barbier, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase II Open-Label, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)[NCT05185622] | Phase 2 | 54 participants (Anticipated) | Interventional | 2022-03-21 | Recruiting | ||
A Phase II Pilot Trial of Vamorolone vs. Placebo for the Treatment of Becker Muscular Dystrophy[NCT05166109] | Phase 2 | 39 participants (Anticipated) | Interventional | 2022-07-07 | Recruiting | ||
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early[NCT02741999] | 20 participants (Actual) | Observational | 2016-04-30 | Completed | |||
Screening to Improve Survival in AL Amyloidosis[NCT04615572] | 35 participants (Actual) | Observational | 2020-08-28 | Completed | |||
The Influence of Amyloid Protein on Myocardial Tissue Characteristics and Function: Prognostic and Diagnostic Significance of Cardiac Magnetic Resonance Findings[NCT02462213] | 0 participants (Actual) | Observational | 2013-10-31 | Withdrawn (stopped due to Unable to recruit patients who had not had MRI first.) | |||
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders[NCT04856267] | 100 participants (Anticipated) | Observational | 2021-05-27 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for prednisolone and Cardiomyopathies
Article | Year |
---|---|
[Cardiac sarcoidosis].
Topics: Cardiomyopathies; Echocardiography; Electrocardiography; Heart Block; Humans; Myocardium; Practice G | 2002 |
[Sarcoidosis of the heart].
Topics: Adrenal Cortex Hormones; Angina Pectoris; Cardiomyopathies; Electrocardiography; Heart Block; Heart | 1982 |
[Cardiac sarcoidosis with myopathy and advanced A-V nodal block in a woman with a previous diagnosis of sarcoidosis].
Topics: Anti-Inflammatory Agents; Cardiomyopathies; Disease Progression; Female; Heart Block; Humans; Middle | 1995 |
2 trials available for prednisolone and Cardiomyopathies
Article | Year |
---|---|
Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions.
Topics: Aged; Cardiomyopathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiograph | 2014 |
The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results.
Topics: Cardiomyopathies; Chronic Disease; Cross-Sectional Studies; Double-Blind Method; Europe; Humans; Imm | 2000 |
62 other studies available for prednisolone and Cardiomyopathies
Article | Year |
---|---|
Optimal Timing of Serial
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednis | 2023 |
An Unusual Case of Cardiomyopathy in a Child.
Topics: Cardiomyopathies; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Immunoglobulins; M | 2020 |
Rare case of infiltrative cardiomyopathy secondary to scleromyxoedema.
Topics: Adult; Cardiomyopathies; Female; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; P | 2020 |
Cardiorespiratory Progression Over 5 Years and Role of Corticosteroids in Duchenne Muscular Dystrophy: A Single-Site Retrospective Longitudinal Study.
Topics: Adolescent; Cardiomyopathies; Child; Child, Preschool; Disease Progression; Glucocorticoids; Humans; | 2020 |
Antimitochondrial Antibody-associated Myopathy with Slowly Progressive Cardiac Dysfunction.
Topics: Autoantibodies; Cardiomyopathies; Female; Humans; Middle Aged; Muscle Weakness; Muscular Diseases; P | 2021 |
Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET.
Topics: Adult; Aged; Cardiomyopathies; Fatty Acids; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; | 2021 |
Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study.
Topics: Adult; Aged; Cardiomyopathies; Chi-Square Distribution; Disease Progression; Female; Glucocorticoids | 2017 |
Isolated Cardiac Sarcoidosis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy.
Topics: Anti-Inflammatory Agents; Arrhythmogenic Right Ventricular Dysplasia; Asian People; Cardiomyopathies | 2018 |
Cardiac Sarcoidosis Concomitant with Large-vessel Aortitis Detected by
Topics: Aortitis; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Glucocorticoids; Humans; Immunosuppressi | 2018 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Cardiomyopathies; Computer Simulation; CRISPR-Associ | 2019 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Cardiomyopathies; Computer Simulation; CRISPR-Associ | 2019 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Cardiomyopathies; Computer Simulation; CRISPR-Associ | 2019 |
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Topics: Aldosterone; Animals; Anti-Inflammatory Agents; Cardiomyopathies; Computer Simulation; CRISPR-Associ | 2019 |
Reversible cardiomyopathy associated with autoimmune polyendocrine syndrome type II.
Topics: Adult; Cardiomyopathies; Delayed Diagnosis; Female; Fludrocortisone; Hormone Replacement Therapy; Hu | 2013 |
Severe myocardial fibrosis in a patient with cardiac sarcoidosis.
Topics: Cardiomyopathies; Fatal Outcome; Fibrosis; Glucocorticoids; Humans; Male; Middle Aged; Myocardium; P | 2013 |
Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis.
Topics: Aged; Anti-Inflammatory Agents; Atrioventricular Block; Cardiac Resynchronization Therapy; Cardiomyo | 2013 |
Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cardiomyopathies; Etanercept; Female; Glucocortic | 2014 |
Interventricular septal thickening as an early manifestation of cardiac sarcoidosis.
Topics: Administration, Oral; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Electrocardiograp | 2014 |
What type of different clinical manifestations can cardiac sarcoidosis present?
Topics: Adult; Arrhythmias, Cardiac; Cardiomyopathies; Coronary Angiography; Disease Progression; Drug Subst | 2015 |
Cardiac sarcoidosis treatment revisited.
Topics: Cardiomyopathies; Female; Humans; Male; Methotrexate; Prednisolone; Sarcoidosis | 2014 |
Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions.
Topics: Cardiomyopathies; Female; Humans; Male; Methotrexate; Prednisolone; Sarcoidosis | 2014 |
[Successful mitral valve replacement in a patient with functional mitral regurgitation induced by cardiac sarcoidosis;report of a case].
Topics: Cardiomyopathies; Diagnostic Imaging; Female; Heart Valve Prosthesis Implantation; Humans; Middle Ag | 2015 |
Effect of Discontinuation of Prednisolone Therapy on Risk of Cardiac Mortality Associated With Worsening Left Ventricular Dysfunction in Cardiac Sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Drug Administration Schedule; Female; Follow-Up Studies; Glucocortico | 2016 |
Detecting Cardiac Sarcoidosis with a Right Atrial Mass Using Transthoracic Echocardiography.
Topics: Adult; Anti-Inflammatory Agents; Atrioventricular Block; Cardiomyopathies; Echocardiography; Female; | 2016 |
Cardiac sarcoidosis: a diagnostic puzzle.
Topics: Anti-Inflammatory Agents; Biopsy; Cardiac Imaging Techniques; Cardiomyopathies; Diagnosis, Different | 2016 |
Diagnosed late cardiac sarcoidosis in a patient with atrioventricular block.
Topics: Anti-Inflammatory Agents; Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; | 2016 |
Contrasting effects of steroids and angiotensin-converting-enzyme inhibitors in a mouse model of dystrophin-deficient cardiomyopathy.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies | 2009 |
Cardiac sarcoidosis complicated with atrioventricular block and wall thinning, edema and fibrosis in left ventricle: confirmed recovery to normal sinus rhythm and visualization of edema improvement by administration of predonisolone.
Topics: Aged; Atrioventricular Block; Cardiomyopathies; Edema, Cardiac; Female; Fibrosis; Heart Rate; Humans | 2011 |
Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Defibrillators, Implantab | 2011 |
Second left ventricular aneurysm newly developed in a patient with untreated cardiac sarcoidosis.
Topics: Biopsy; Cardiomyopathies; Glucocorticoids; Heart Aneurysm; Heart Ventricles; Humans; Magnetic Resona | 2010 |
Sudden reversible pacemaker failure in a patient with cardiac sarcoidosis: an unfortunate case of ventricular septal pacing.
Topics: Adult; Anti-Inflammatory Agents; Atrioventricular Block; Cardiomyopathies; Humans; Male; Pacemaker, | 2012 |
Isolated primary cardiac sarcoidosis presenting as acute heart failure.
Topics: Acute Disease; Biopsy, Needle; Cardiomyopathies; Diagnosis, Differential; Dyspnea; Echocardiography; | 2013 |
Usefulness of 18FDG/13N-ammonia PET imaging for evaluation of the cardiac damage in Churg-Strauss syndrome.
Topics: Ammonia; Cardiomyopathies; Churg-Strauss Syndrome; Female; Fluorodeoxyglucose F18; Humans; Middle Ag | 2004 |
Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged | 2005 |
Takotsubo (ampulla-shaped) cardiomyopathy associated with microscopic polyangiitis.
Topics: Aged; Arteritis; Biopsy; Cardiomyopathies; Coronary Vessels; Diagnosis, Differential; Drug Therapy, | 2005 |
Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy.
Topics: Acute Disease; Anti-Inflammatory Agents; Cardiomyopathies; Female; Humans; Hypereosinophilic Syndrom | 2005 |
National survey on status of steroid therapy for cardiac sarcoidosis in Japan.
Topics: Adult; Aged; Cardiomyopathies; Drug Administration Schedule; Female; Glucocorticoids; Health Care Su | 2005 |
Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation.
Topics: Anti-Inflammatory Agents; Cardiomyopathies; Contrast Media; Electrocardiography; Female; Gadolinium | 2007 |
Clinical analysis of sarcoidosis presenting with heterochronic cardiac involvement.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathies; Female; Glucocorticoids; Hum | 2007 |
A failed case to diagnose cardiac sarcoidosis presenting advanced atrioventricular block.
Topics: Anti-Inflammatory Agents; Atrioventricular Block; Cardiomyopathies; Diagnostic Errors; Fatal Outcome | 2008 |
Steroid treatment deteriorated ventricular tachycardia in a patient with right ventricle-dominant cardiac sarcoidosis.
Topics: Cardiomyopathies; Glucocorticoids; Humans; Male; Middle Aged; Prednisolone; Sarcoidosis; Tachycardia | 2009 |
Surgical removal of a left ventricular thrombus associated with cardiac sarcoidosis.
Topics: Adult; Anticoagulants; Cardiomyopathies; Cerebral Infarction; Glucocorticoids; Heart Diseases; Heart | 2008 |
Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone.
Topics: Adult; Cardiomyopathies; Digitalis Glycosides; Electrocardiography; Female; Furosemide; Heart Ventri | 1984 |
[Lymphogranulomatosis and heart involvement].
Topics: Adult; Cardiomyopathies; Cobalt Radioisotopes; Cyclophosphamide; Hodgkin Disease; Humans; Male; Pred | 1981 |
Heart transplantation is a valid therapeutic option for anthracycline cardiomyopathy.
Topics: Actuarial Analysis; Adult; Azathioprine; Cardiomyopathies; Cyclosporine; Daunorubicin; Doxorubicin; | 1995 |
Sarcoidosis with cardiac involvement.
Topics: Cardiomyopathies; Female; Humans; Middle Aged; Prednisolone; Sarcoidosis | 1995 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Cardiomyopathies; Colchicine; Drug Therapy, Combination | 1998 |
Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment.
Topics: Cardiomyopathies; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prednisolo | 1998 |
Successfully treated complete atrioventricular block with corticosteroid in a patient with cardiac sarcoidosis: usefulness of gallium-67 and thallium-201 scintigraphy.
Topics: Aged; Cardiomyopathies; Diagnosis, Differential; Gallium Radioisotopes; Glucocorticoids; Heart Block | 2000 |
Demonstration of transient entrainment in monomorphic sustained ventricular tachycardia associated with cardiac sarcoidosis.
Topics: Cardiomyopathies; Electric Stimulation Therapy; Electrocardiography; Humans; Male; Middle Aged; Pred | 2000 |
Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cardiomyopathies; Contrast Media; Female; Gadolinium DTPA; Hu | 2001 |
Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis. Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis.
Topics: Adult; Anti-Inflammatory Agents; Cardiac Pacing, Artificial; Cardiomyopathies; Defibrillators, Impla | 2001 |
[A case of sarcoidosis involving multiple organs that showed significant improvement as the serum KL-6 level fell after steroid therapy].
Topics: Adult; Anti-Inflammatory Agents; Antigens; Antigens, Neoplasm; Biomarkers; Cardiomyopathies; Glycopr | 2001 |
[Notes on sarcoidosis of the heart (author's transl)].
Topics: Cardiomyopathies; Female; Humans; Middle Aged; Prednisolone; Radiography; Sarcoidosis | 1979 |
Sarcoidosis with incomplete bilateral bundle branch block pattern disappearing following steroid therapy: an electrophysiological study.
Topics: Bundle of His; Bundle-Branch Block; Cardiac Catheterization; Cardiomyopathies; Electric Stimulation; | 1976 |
Sarcoid heart disease--results of follow-up investigations.
Topics: Adult; Cardiomyopathies; Female; Follow-Up Studies; Humans; Male; Prednisolone; Sarcoidosis; Time Fa | 1991 |
[A case of cardiac sarcoidosis with various electrocardiographic change].
Topics: Cardiomyopathies; Electrocardiography; Female; Humans; Lung Diseases; Mexiletine; Middle Aged; Pacem | 1989 |
Clinical study on cardiac sarcoidosis.
Topics: Adult; Aged; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Heart; Humans; Male; M | 1986 |
[A case of myocardial sarcoidosis with corticosteroids therapy].
Topics: Aged; Cardiomyopathies; Eye Diseases; Humans; Male; Myocardium; Prednisolone; Sarcoidosis; Tachycard | 1988 |
[A case of allergic granulomatous angiitis with special reference to cardiac lesions].
Topics: Adult; Cardiomyopathies; Female; Granuloma; Humans; Prednisolone; Vasculitis | 1986 |
[Steroid cardiopathy].
Topics: Aged; Cardiomyopathies; Humans; Male; Prednisolone; Tachycardia, Paroxysmal | 1986 |
[Heart antibodies in sarcoidosis].
Topics: Adult; Antibody Specificity; Autoantibodies; Autoantigens; Cardiomyopathies; Female; Fluorescent Ant | 1985 |
Human heart transplantation.
Topics: Antibodies, Anti-Idiotypic; Azathioprine; Cardiac Catheterization; Cardiac Output; Cardiomegaly; Car | 1969 |
Prevention of various forms of metabolic myocardial necrosis by catatoxic steroids.
Topics: Animals; Cardiomyopathies; Desoxycorticosterone; Digitoxin; Disease Models, Animal; Ethylestrenol; F | 1970 |
[Polymyositis with cardiac symptomatology. Report of 2 cases].
Topics: Adult; Aged; Cardiomyopathies; Dermatomyositis; Electrocardiography; Female; Heart; Humans; Male; Me | 1969 |